Rep. Barton seeks more financial information on FDA's Thompson, continues questions regarding Wyeth.
REP. BARTON CONTINUES TO SEEK INFORMATION ON FDA's THOMPSON, requesting clarification of several transactions involving Associate Commissioner for Legislative Affairs Diane Thompson's personal finances. In an Aug. 3 letter to FDA Commissioner Kessler, House Commerce/Oversight Subcommittee Chairman Barton (R-Tex.) inquires whether Thompson "received prior clearance" from the HHS Ethics Office for two gifts listed in her Executive Branch Public Financial Disclosure Report for 1994: a $150 gift from the National Consumers League and a $150 gift from the Society for the Advancement of Women's Health Research.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth